British study: diabetes drugs reduce visceral fat by 15%


Pile up Visceral fat Inside the abdomen, it occupies space around the internal organs, which puts you at risk of heart disease, diabetes and stroke, so it must be eliminated to prevent many diseases and dangerous complications that reach the risk of death.

Diabetes drugs help reduce organoleptic fats

According to a study published in The New England Journal of MedicineIt has been shown that diabetes drugs contribute to the elimination of visceral fat and the complications resulting from it, especially belly fat.

The study examined 1,961 people and determined a body mass index (BMI) (BMI) Which exceeded 27, which means that they were classified as “overweight, as they suffered from a rapid heartbeat as a result of the accumulation of these fats,” and the study participants took a drug intended for diabetics, which is a synthetic version of the hormone glucagon.

The study participants did not suffer from diabetes, but they continued to take the drug for 68 weeks in one dose per day, as the drug acts on the appetite centers in the brain and intestine, and causes a feeling of fullness..

The study found that the drug intended for diabetics succeeded in reducing belly and body fat in a remarkable way, as fat was measured by measuring the absorption of dual energy, which is a technique that assesses body composition, body fat and fats in the stomach area, and shows a significant decrease in the amounts of fat in the abdominal area.

The researchers confirmed that the participants succeeded in losing their weight and belly fat by 15% after taking the indicated drug, and thus the risk factors related to heart disease and diabetes were reduced.


Please enter your comment!
Please enter your name here